methylbenzoprim has been researched along with pyrimethamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, RJ; Meek, MA; Schwalbe, CH; Stevens, MF | 1 |
| Lambert, PA; O'Shea, DM; Phillip, KS; Queener, SF; Rathbone, DL; Schwalbe, CH; Stevens, MF | 1 |
| Alberton, M; Buoncervello, M; Cerbelli, B; d'Amati, G; Gabriele, L; Gambardella, L; Giammarioli, AM; Golding, BT; Griffin, RJ; Macchia, D; Malorni, W; Spada, M; Tommasino, C | 1 |
3 other study(ies) available for methylbenzoprim and pyrimethamine
| Article | Year |
|---|---|
Structural studies on bioactive compounds. 8. Synthesis, crystal structure, and biological properties of a new series of 2,4-diamino-5-aryl-6-ethylpyrimidine dihydrofolate reductase inhibitors with in vivo activity against a methotrexate-resistant tumor c
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Crystallization; Folic Acid Antagonists; Leukemia, Experimental; Liver; Methotrexate; Mice; Molecular Structure; Pyrimidines; Rats; Structure-Activity Relationship; Tumor Cells, Cultured | 1989 |
Structural studies on bioactive compounds. 28. Selective activity of triazenyl-substituted pyrimethamine derivatives against Pneumocystis carinii dihydrofolate reductase.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Crystallization; Crystallography, X-Ray; Folic Acid Antagonists; Liver; Models, Molecular; Molecular Structure; Pneumocystis; Pyrimidines; Rats; Solubility; Tetrahydrofolate Dehydrogenase; Triazenes | 1997 |
New derivatives of the antimalarial drug Pyrimethamine in the control of melanoma tumor growth: an in vitro and in vivo study.
Topics: Animals; Antineoplastic Agents; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Mice; Mice, SCID; Neoplasm Metastasis; Pyrimethamine; Pyrimidines; Xenograft Model Antitumor Assays | 2016 |